Personal tools

MCL coexpression mm9:272: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.687738219048156,0.755996456683227,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.482424358947677,0.204093579732844,0.331150240384848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0994554632344034,0.108620321524749,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.747366558868196,0.679308786624253,0.64884764453117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0424616899933645,0.0530480122014902,0,0,0.0935585710841254,0.0598244186619439,0.0417740847988257,0.0616083799021044,0.041718751492076,0.0773372897074742,0,0.0480053095083702,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.687738219048156,0.755996456683227,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.482424358947677,0.204093579732844,0.331150240384848,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0994554632344034,0.108620321524749,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.747366558868196,0.679308786624253,0.64884764453117,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0424616899933645,0.0530480122014902,0,0,0.0935585710841254,0.0598244186619439,0.0417740847988257,0.0616083799021044,0.041718751492076,0.0773372897074742,0,0.0480053095083702,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=GO:0042163;interleukin-12 beta subunit binding;0.03681586588506;16159!GO:0045083;negative regulation of interleukin-12 biosynthetic process;0.03681586588506;18033!GO:0005143;interleukin-12 receptor binding;0.03681586588506;16159!GO:0019972;interleukin-12 binding;0.0441705672980616;16159!GO:0043514;interleukin-12 complex;0.0441705672980616;16159!
|gostat_on_MCL_coexpression=GO:0042163;interleukin-12 beta subunit binding;0.03681586588506;16159!GO:0045083;negative regulation of interleukin-12 biosynthetic process;0.03681586588506;18033!GO:0005143;interleukin-12 receptor binding;0.03681586588506;16159!GO:0019972;interleukin-12 binding;0.0441705672980616;16159!GO:0043514;interleukin-12 complex;0.0441705672980616;16159!
|ontology_enrichment_celltype=CL:0000988!9.73e-07!32;CL:0002032!9.73e-07!32;CL:0000037!9.73e-07!32;CL:0000566!9.73e-07!32;CL:0000837!9.73e-07!32
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002370!1.38e-14!23;UBERON:0000974!1.38e-14!23;UBERON:0004807!1.38e-14!23;UBERON:0005058!1.38e-14!23;UBERON:0003351!1.38e-14!23;UBERON:0009113!1.38e-14!23;UBERON:0003295!1.38e-14!23;UBERON:0009722!1.38e-14!23;UBERON:0005562!1.38e-14!23;UBERON:0007690!1.38e-14!23;UBERON:0006562!6.24e-14!24;UBERON:0003408!6.24e-14!24;UBERON:0001557!6.24e-14!24;UBERON:0001042!6.24e-14!24;UBERON:0008814!6.24e-14!24;UBERON:0009145!6.24e-14!24;UBERON:0000072!2.97e-12!27;UBERON:0004177!2.50e-11!29;UBERON:0005057!2.50e-11!29;UBERON:0002390!1.54e-10!45;UBERON:0003061!1.54e-10!45;UBERON:0002193!8.89e-10!48;UBERON:0002405!8.89e-10!48;UBERON:0000077!3.50e-09!35;UBERON:0000063!3.50e-09!35;UBERON:0007811!6.79e-09!36;UBERON:0000065!1.16e-07!41;UBERON:0001004!1.88e-07!42;UBERON:0000153!2.99e-07!43
}}
}}

Revision as of 18:55, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr12:79457764..79457771,+p@chr12:79457764..79457771
+
Mm9::chr13:28931259..28931267,+p@chr13:28931259..28931267
+
Mm9::chr14:77090431..77090436,+p@chr14:77090431..77090436
+
Mm9::chr14:77094832..77094840,-p@chr14:77094832..77094840
-
Mm9::chr15:97651417..97651453,-p@chr15:97651417..97651453
-
Mm9::chr16:49792628..49792641,-p@chr16:49792628..49792641
-
Mm9::chr16:49854460..49854472,+p@chr16:49854460..49854472
+
Mm9::chr16:91793806..91793817,+p@chr16:91793806..91793817
+
Mm9::chr17:32246056..32246059,+p@chr17:32246056..32246059
+
Mm9::chr18:15366299..15366306,-p@chr18:15366299..15366306
-
Mm9::chr18:35988452..35988469,+p@chr18:35988452..35988469
+
Mm9::chr1:137607949..137607972,+p@chr1:137607949..137607972
+
Mm9::chr1:138143330..138143333,-p@chr1:138143330..138143333
-
Mm9::chr1:38834429..38834436,-p@chr1:38834429..38834436
-
Mm9::chr1:92946103..92946113,+p@chr1:92946103..92946113
+
Mm9::chr3:135271365..135271376,-p20@Nfkb1
Mm9::chr3:58934672..58934686,-p12@P2ry14
Mm9::chr3:68497952..68497969,+p@chr3:68497952..68497969
+
Mm9::chr3:68498017..68498026,+p@chr3:68498017..68498026
+
Mm9::chr5:137041384..137041400,-p@chr5:137041384..137041400
-
Mm9::chr5:148211876..148211908,-p1@Flt3
Mm9::chr5:148211928..148211953,-p2@Flt3
Mm9::chr5:148212024..148212049,+p@chr5:148212024..148212049
+
Mm9::chr5:39267947..39267996,-p1@Clnk
Mm9::chr6:48539449..48539467,+p4@Gm5111
Mm9::chr6:48539483..48539498,+p2@Gm5111
Mm9::chr6:48539505..48539527,+p5@Gm5111
Mm9::chr6:52184225..52184236,-p@chr6:52184225..52184236
-
Mm9::chr7:149628870..149628902,+p6@Tnni2
Mm9::chr9:57282766..57282792,-p@chr9:57282766..57282792
-
Mm9::chr9:71010895..71010907,-p6@Aqp9


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0042163interleukin-12 beta subunit binding0.03681586588506
GO:0045083negative regulation of interleukin-12 biosynthetic process0.03681586588506
GO:0005143interleukin-12 receptor binding0.03681586588506
GO:0019972interleukin-12 binding0.0441705672980616
GO:0043514interleukin-12 complex0.0441705672980616



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Uber Anatomy
Ontology termp-valuen
thymus1.38e-1423
neck1.38e-1423
respiratory system epithelium1.38e-1423
hemolymphoid system gland1.38e-1423
pharyngeal epithelium1.38e-1423
thymic region1.38e-1423
pharyngeal gland1.38e-1423
entire pharyngeal arch endoderm1.38e-1423
thymus primordium1.38e-1423
early pharyngeal endoderm1.38e-1423
pharynx6.24e-1424
gland of gut6.24e-1424
upper respiratory tract6.24e-1424
chordate pharynx6.24e-1424
pharyngeal arch system6.24e-1424
pharyngeal region of foregut6.24e-1424
segment of respiratory tract2.97e-1227
hemopoietic organ2.50e-1129
immune organ2.50e-1129
hematopoietic system1.54e-1045
blood island1.54e-1045
hemolymphoid system8.89e-1048
immune system8.89e-1048
mixed endoderm/mesoderm-derived structure3.50e-0935
organ segment3.50e-0935
craniocervical region6.79e-0936
respiratory tract1.16e-0741
respiratory system1.88e-0742
anterior region of body2.99e-0743


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:272&oldid=2154977"